uBiome Awards Grant to MEBO Research, a Public Charity, to Study the Dynamic of Gut Microbiota in Idiopathic Malodor Production
![]() |
Click on icon to see article |
A press release was published today about the nearly $500,000 worth of microbiome research grant awarded to MEBO by uBiome for the "Microbial Basis of Systemic Malodor and PATM Conditions (PATM)", ClinicalTrials.gov Identifier: NCT03582826.
The aim of this study is to support the gathering of comprehensive data to assess the correlation of gut microbiome to physical and psycho-social health conditions.
“This study is exciting because it advances our understanding of metabolic dysfunction and its correlation to rare disease,” said Jessica Richman, PhD, co-founder and CEO of uBiome. “We are honored to partner with MEBO Research to support this novel study on this understudied patient population.”
Dr. Irene Gabashvili, PhD, is Scientific Director of MEBO Research and Principal Investigator. A Stanford Medicine and HP Labs alumna, Dr. Gabashvili has authored numerous publications and has led several diverse biomedical and software development projects. In addition, as founder of Aurametrix, Inc., she developed a health-management platform to alleviate metabolic disorders and maximize health and wellbeing.
This very generous grant allows for MEBO to include participants, who experience similar physical symptoms with psycho-social health conditions, from 6 continents of the world, including Africa, Europe, Asia, North America, South America, and Australia. Our profound gratitude goes out to the uBiome team for their very kind and professional support throughout this process.
María

Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.com
www.meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)

0 comments: